When adopting these criteria, the probability to identify germline CDH1 mutations is estimated to be around 3% in high‐risk LBC patients,21 and 0.5% in unselected LBCs.22 Here, CDH1 is linked to CDH1-related diffuse gastric and lobular breast cancer syndrome.